NanoViricides, Inc. reported earnings results for the full year ended June 30, 2023. For the full year, the company reported net loss was USD 8.59 million compared to USD 8.11 million a year ago. Basic loss per share from continuing operations was USD 0.74 compared to USD 0.7 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.03 USD | +20.83% | +79.65% | +99.02% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+99.02% | 19.79M | |
+2.93% | 106B | |
+7.02% | 23.47B | |
-14.60% | 21.9B | |
-7.05% | 18.77B | |
-38.55% | 17.85B | |
-8.83% | 16.78B | |
+5.51% | 14.41B | |
+37.49% | 12.86B | |
+329.39% | 8.78B |
- Stock Market
- Equities
- NNVC Stock
- News NanoViricides, Inc.
- NanoViricides, Inc. Reports Earnings Results for the Full Year Ended June 30, 2023